Medacta Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 3/6
Medacta Group yıllık ortalama 18.1% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 10.6% annual. Gelirler growing yılda ortalama 14% oranında artmaktadır. Medacta Group'in özkaynak karlılığı 16.3% ve net marjı 10.3%'dir.
Anahtar bilgiler
18.1%
Kazanç büyüme oranı
20.5%
EPS büyüme oranı
| Medical Equipment Sektör Büyümesi | 11.1% |
| Gelir büyüme oranı | 14.0% |
| Özkaynak getirisi | 16.3% |
| Net Marj | 10.3% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
The Price Is Right For Medacta Group SA (VTX:MOVE)
Nov 22
Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Mar 29Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Feb 22Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around
Feb 07Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult
Dec 18Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Dec 04Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Nov 15Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)
Oct 30If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity
Oct 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Aug 11Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Jul 27Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital
Jul 03At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Medacta Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 544 | 56 | 271 | 20 |
| 31 Mar 24 | 528 | 52 | 262 | 19 |
| 31 Dec 23 | 511 | 47 | 252 | 19 |
| 30 Sep 23 | 496 | 49 | 245 | 17 |
| 30 Jun 23 | 481 | 50 | 237 | 17 |
| 31 Mar 23 | 459 | 48 | 228 | 16 |
| 31 Dec 22 | 437 | 46 | 220 | 15 |
| 30 Sep 22 | 417 | 47 | 212 | 14 |
| 30 Jun 22 | 397 | 47 | 203 | 14 |
| 31 Mar 22 | 380 | 49 | 193 | 12 |
| 31 Dec 21 | 363 | 52 | 182 | 11 |
| 30 Sep 21 | 354 | 54 | 173 | 10 |
| 30 Jun 21 | 345 | 57 | 164 | 8 |
| 31 Mar 21 | 324 | 47 | 160 | 7 |
| 31 Dec 20 | 302 | 37 | 155 | 7 |
| 30 Sep 20 | 298 | 24 | 166 | 7 |
| 30 Jun 20 | 294 | 10 | 177 | 7 |
| 31 Mar 20 | 302 | 11 | 177 | 8 |
| 31 Dec 19 | 311 | 12 | 176 | 8 |
| 30 Sep 19 | 301 | 22 | 162 | 6 |
| 30 Jun 19 | 291 | 33 | 147 | 5 |
| 31 Mar 19 | 282 | 39 | 143 | 5 |
| 31 Dec 18 | 273 | 46 | 139 | 4 |
| 31 Dec 17 | 245 | 33 | 129 | 3 |
| 31 Dec 16 | 219 | 39 | 113 | 3 |
Kaliteli Kazançlar: MOVE yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: MOVE 'nin mevcut net kar marjları (10.3%) geçen yılın (10.3%) değerinden daha düşüktür.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: MOVE şirketinin kazancı son 5 yılda yılda 18.1% oranında arttı.
Büyüme Hızlandırma: MOVE 'un son bir yıldaki kazanç büyümesi ( 13% ) 5 yıllık ortalamasının ( 18.1% /yıl) altındadır.
Kazançlar vs. Sektör: MOVE geçen yılki kazanç büyümesi ( 13% ) Medical Equipment sektörünün -1.6% değerini aştı.
Özkaynak Getirisi
Yüksek ROE: MOVE 'nin Özsermaye Getirisi ( 16.3% ) düşük olarak değerlendiriliyor.